|  | Duration (day) |  |  |
---|---|---|---|---|
Parameter | Groups | 0 | 14 | 28 |
PCV (%) | Control | 39.40 ± 0.51b1 | 41.40 ± 0.51b2 | 42.80 ± 0.37ab2 |
150 mgkg−1 O3FA | 37.00 ± 0.45a1 | 39.20 ± 0.37a2 | 42.20 ± 0.74ab3 | |
 | 250 mgkg−1 O3FA | 35.80 ± 0.37a1 | 38.20 ± 0.37a2 | 40.80 ± 0.37a3 |
RBC (× 106 cells/μl) | Control | 7.36 ± 0.07a1 | 7.38 ± 0.07a1 | 7.39 ± 0.07a1 |
150 mgkg−1 O3FA | 7.27 ± 0.06a1 | 7.30 ± 0.06a1 | 7.29 ± 0.06a1 | |
250 mgkg−1 O3FA | 7.36 ± 0.05a1 | 7.37 ± 0.05a1 | 7.37 ± 0.04a1 | |
Hb (g/dl) | Control | 13.13 ± 0.17b1 | 13.80 ± 0.17b12 | 13.94 ± 0.29a2 |
150 mgkg−1 O3FA | 12.47 ± 0.25a1 | 13.07 ± 0.12a1 | 14.73 ± 0.24a2 | |
 | 250 mgkg−1 O3FA | 11.93 ± 0.12a1 | 12.73 ± 0.13a2 | 14.07 ± 0.29a3 |
WBC (× 103/μl) | Control | 8.90. ± 0.02a1 | 9.00 ± 0.03a1 | 9.05 ± 0.04a1 |
150 mgkg−1 O3FA | 8.99 ± 0.01a1 | 9.00 ± 0.02ab1 | 9.04 ± 0.02a1 | |
 | 250 mgkg−1 O3FA | 8.96 ± 0.02a1 | 9.06 ± 0.01b2 | 9.05 ± 0.03a2 |
MCV (fl) | Control | 53.52 ± 0.47a1 | 56.08 ± 0.44c2 | 57.90 ± 0.37a3 |
150 mgkg−1 O3FA | 51.18 ± 0.52b1 | 53.74 ± 0.29b2 | 57.90 ± 0.91b3 | |
 | 250 mgkg−1 O3FA | 48.63 ± 0.72a1 | 51.82 ± 0.69a2 | 55.35 ± 0.74b3 |
MCH (pg) | Control | 17.84 ± 0.15c1 | 18.51 ± 0.18a2 | 18.84 ± 0.26a2 |
150 mgkg−1 O3FA | 17.15 ± 0.25b1 | 17.91 ± 0.95b2 | 20.21 ± 0.31c3 | |
 | 250 mgkg−1 O3FA | 16.21 ± 0.24a1 | 17.27 ± 0.23a2 | 19.09 ± 0.47b3 |
MCHC (g/dl) | Control | 33.33 ± 0.07a1 | 33.33 ± 0.37a1 | 32.55 ± 0.43a1 |
150 mgkg−1 O3FA | 33.68 ± 0.35a1 | 33.32 ± 0.29a1 | 34.91 ± 0.03b2 | |
 | 250 mgkg−1 O3FA | 33.33 ± 0.19a1 | 33.33 ± 0.46a1 | 34.47 ± 0.54b2 |